PAHC
Phibro Animal Health Corporation
$37.07
-$1.39(-3.61%)
65
Overall
90
Value
63
Tech
44
Quality
Market Cap
$1.32B
Volume
645.15K
52W Range
$16.16 - $38.83
Target Price
$28.00
Order:
Income Statement
| Metric | Trend | Chart | 2016 Jun | 2017 Jun | 2018 Jun | 2019 Jun | 2020 Jun | 2021 Jun | 2022 Jun | 2023 Jun | 2024 Jun | 2025 Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $751.5M | $764.3M | $820.0M | $828.0M | $800.4M | $833.4M | $942.3M | $977.9M | $1.0B | $1.3B | ||
| Total Revenue | $751.5M | $764.3M | $820.0M | $828.0M | $800.4M | $833.4M | $942.3M | $977.9M | $1.0B | $1.3B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-512.5M | $-516.0M | $-553.1M | $563.4M | $543.5M | $562.0M | $656.9M | $679.7M | $704.6M | $896.3M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $239.0M | $248.2M | $266.9M | $264.6M | $256.9M | $271.4M | $285.4M | $298.2M | $313.1M | $399.9M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $153.3M | $150.3M | $168.0M | $181.4M | $187.7M | $196.5M | $206.4M | $226.4M | $259.8M | $289.5M | ||
| Research & Development | $-11.0M | $-9.4M | $-10.0M | $12.1M | $13.7M | $17.8M | $20.8M | $24.4M | $29.2M | -- | ||
| Research Expense | -- | -- | -- | $12.1M | $13.7M | $17.8M | $20.8M | -- | -- | -- | ||
| Selling, General & Administrative | $153.3M | $150.3M | $168.0M | $181.4M | $187.7M | $196.5M | $206.4M | $226.4M | $259.8M | $289.5M | ||
| Selling & Marketing Expenses | $153.3M | $150.3M | $168.0M | -- | -- | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $-8.1M | $-7.7M | $-33.4M | $181.4M | $187.7M | $196.5M | $206.4M | $226.4M | $259.8M | $289.5M | ||
| Salaries & Wages | $-4.4M | $-1.9M | $-334.0K | $2.3M | $-517.0K | $-1.4M | $-1.3M | -- | $475.0K | $717.0K | ||
| Depreciation & Amortization | $-23.5M | $-26.0M | $-26.9M | $27.6M | $32.3M | $31.9M | $32.7M | $34.0M | $36.2M | -- | ||
| Depreciation & Amortization | $-23.5M | $-26.0M | $-26.9M | $27.6M | $32.3M | $31.9M | $32.7M | -- | -- | -- | ||
| Amortization | $-6.5M | $-7.0M | $-6.7M | $28.2M | $53.6M | $53.5M | $53.8M | $54.0M | $55.6M | -- | ||
| Other Operating Expenses | $-8.5M | $-1.5M | $-1.7M | $-6.3M | $-10.7M | $-1.9M | $-5.3M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $85.7M | $97.9M | $-721.1M | $83.2M | $69.2M | $74.9M | $79.0M | $71.8M | $53.3M | $110.5M | ||
| EBITDA | $84.4M | $90.7M | $102.3M | $111.7M | $101.6M | $110.2M | $117.7M | $104.1M | $66.7M | $150.2M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $-16.8M | $-16.9M | $-13.6M | $11.8M | $13.7M | $11.9M | $12.1M | $15.3M | $18.5M | $34.6M | ||
| Intinc | $256.0K | $2.0M | $1.7M | $1.9M | $1.8M | $838.0K | $816.0K | $3.4M | $4.5M | $2.6M | ||
| Net Non-Operating Interest Income/Expense | $16.6M | $-14.9M | $11.9M | $-11.8M | $-12.9M | $-12.9M | $-11.9M | $-15.3M | $-18.5M | $-34.6M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | -- | -- | $1.2M | -- | -- | -- | ||
| Other Income/Expense | $-17.5M | $2.6M | $-820.0M | $-17.9M | $19.0M | $264.0K | $5.2M | $2.8M | $12.3M | -- | ||
| Other Special Charges | -- | $-2.6M | $820.0M | $16.2M | -- | -- | -- | -- | -- | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-1.5M | $-1.4M | $-1.1M | -- | $425.0K | -- | -- | -- | -- | -- | ||
| Special Income Charges | $1.5M | $3.6M | $2.6M | $-1.2M | $-1.0M | $-1.3M | $-1.0M | $-1.5M | $899.0K | $2.9M | ||
| Impairment of Capital Assets | -- | $-2.2M | $-1.5M | $1.2M | $1.0M | $1.3M | $1.0M | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $59.9M | $63.7M | $74.5M | $83.3M | $69.2M | $78.3M | $84.4M | $69.4M | $29.5M | $102.6M | ||
| Pre-Tax Income | $76.8M | $80.5M | $88.1M | $71.5M | $55.5M | $66.5M | $72.3M | $54.1M | $10.9M | $68.0M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-6.0M | $15.9M | $23.2M | $16.8M | $22.0M | $12.1M | $23.2M | $21.5M | $8.5M | $19.7M | ||
| NET INCOME | ||||||||||||
| Net Income | $82.7M | $64.6M | $64.9M | $54.7M | $33.6M | $54.4M | $49.2M | $32.6M | $2.4M | $48.3M | ||
| Net Income (Continuing Operations) | $82.7M | $64.6M | $64.9M | $54.7M | $33.6M | $54.4M | $49.2M | $32.6M | $2.4M | $48.3M | ||
| Net Income (Discontinued Operations) | $82.7M | $64.6M | $64.9M | $54.7M | $33.6M | $54.4M | $49.2M | $32.6M | $2.4M | $48.3M | ||
| Net Income (Common Stockholders) | $82.7M | $64.6M | $64.9M | $54.7M | $33.6M | $54.4M | $49.2M | $32.6M | $2.4M | $48.3M | ||
| Normalized Income | -- | -- | -- | -- | -- | $54.0M | -- | -- | -- | $64.4M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-359.2M | $-365.7M | $-385.1M | $744.8M | $731.2M | $758.5M | $863.3M | $906.0M | $964.4M | $1.2B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $39.3M | $39.5K | $40.2K | $40.4K | $40.5K | $40.5K | $40.5M | $40.5M | $40.5M | $40.5M | ||
| Average Shares Outstanding (Diluted) | $40.0M | $40.0K | $40.4K | $40.5K | $40.5K | $40.5K | $40.5M | $40.5M | $40.5M | $40.7M | ||
| Shares Outstanding | $39.4M | $39.9M | $40.4M | $40.5M | $40.5M | $40.5M | $40.5M | $40.5M | $40.5M | $40.5M | ||
| Basic EPS | $2.11 | $1.63 | $1.61 | $1.35 | $0.83 | $1.34 | $1.21 | $0.81 | $0.06 | $1.19 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $1.35 | $0.83 | $1.34 | $1.21 | $0.81 | $0.06 | $1.19 | ||
| Diluted EPS | $2.07 | $1.61 | $1.61 | $1.35 | $0.83 | $1.34 | $1.21 | $0.81 | $0.06 | $1.19 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $1.35 | $0.83 | $1.34 | $1.21 | $0.81 | $0.06 | $1.19 | ||
| Dividend Per Share | $0.40 | $0.40 | $0.40 | $0.46 | -- | $0.48 | $0.48 | $0.48 | $0.48 | $0.48 | ||
| OTHER METRICS | ||||||||||||
| Earnings from equity interest | $15.7M | $15.8M | $16.1M | $-18.6M | $-19.4M | $-19.4M | -- | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | $15.7M | $15.8M | $16.1M | $-18.6M | $-19.4M | $-19.4M | -- | -- | -- | -- | ||
| Gain On Sale Of Business | -- | $-1.7M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Net Operating Interest Income Expense | $-16.6M | $-14.9M | $-11.9M | -- | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | -- | -- | -- | -- | $-899.0K | $-2.9M | ||
| Other Gand A | $-8.1M | $-7.7M | $-33.4M | $181.4M | $187.7M | $196.5M | $206.4M | $226.4M | $259.8M | $289.5M | ||
| Other Impairment Of Capital Assets | -- | $-1.6M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Write Off | $-67.0K | $-96.0K | $-122.0K | $-1.7M | $-428.0K | $264.0K | $180.0K | -- | -- | -- | ||
| Rent And Landing Fees | $-8.1M | $-7.7M | $-8.5M | $9.1M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $153.3M | $150.3M | $168.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Othspecchg | -- | -- | -- | $-1.5M | -- | -- | -- | -- | -- | -- | ||
| Restruct | $-1.5M | $-1.4M | $-1.1M | -- | $425.0K | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PAHC | $37.07 | -3.6% | 645.15K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Phibro Animal Health Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW